Scarica l'app Stockscreener
43.95
1.17%
-0.52
Dopo l'orario di chiusura:
43.95
Precedente Chiudi:
$44.47
Aprire:
$44.55
Volume 24 ore:
446.26K
Relative Volume:
1.02
Capitalizzazione di mercato:
$1.38B
Reddito:
$566.77M
Utile/perdita netta:
$48.16M
Rapporto P/E:
36.93
EPS:
1.19
Flusso di cassa netto:
$274.29M
1 W Prestazione:
-5.24%
1M Prestazione:
+26.11%
6M Prestazione:
+46.70%
1 anno Prestazione:
+46.50%
Intervallo 1D:
$43.78
$45.33
Intervallo di 1 settimana:
$43.59
$46.48
Portata 52W:
$23.23
$48.18
Collegium Pharmaceutical Inc Stock (COLL) Company Profile
Nome
Collegium Pharmaceutical Inc
Settore
Telefono
781-713-3699
Indirizzo
100 TECHNOLOGY CENTER DRIVE, STOUGHTON, MA
Confronta COLL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
COLL
Collegium Pharmaceutical Inc
|
43.95 | 1.41B | 566.77M | 48.16M | 274.29M | 1.19 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Collegium Pharmaceutical Inc Stock (COLL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-01-10 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-30 | Aggiornamento | H.C. Wainwright | Neutral → Buy |
| 2024-06-07 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-05-10 | Downgrade | Needham | Buy → Hold |
| 2024-05-10 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-01-04 | Downgrade | Jefferies | Buy → Hold |
| 2023-08-25 | Reiterato | Needham | Buy |
| 2023-05-02 | Ripresa | Jefferies | Buy |
| 2022-08-08 | Downgrade | H.C. Wainwright | Buy → Neutral |
| 2022-02-15 | Aggiornamento | Cantor Fitzgerald | Neutral → Overweight |
| 2021-08-06 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| 2021-01-11 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-14 | Iniziato | BWS Financial | Sell |
| 2020-05-27 | Iniziato | Guggenheim | Neutral |
| 2020-02-19 | Ripresa | Jefferies | Buy |
| 2019-10-30 | Reiterato | Needham | Buy |
| 2019-05-03 | Ripresa | H.C. Wainwright | Buy |
| 2019-04-12 | Ripresa | Janney | Buy |
| 2019-03-20 | Iniziato | SunTrust | Hold |
| 2019-01-16 | Reiterato | Needham | Buy |
| 2018-03-08 | Reiterato | H.C. Wainwright | Buy |
| 2018-02-07 | Reiterato | Needham | Buy |
| 2017-12-05 | Reiterato | Needham | Buy |
| 2017-09-11 | Iniziato | H.C. Wainwright | Buy |
| 2017-05-11 | Reiterato | Needham | Buy |
| 2016-09-13 | Iniziato | Gabelli & Co | Buy |
| 2015-06-01 | Iniziato | Jefferies | Buy |
| 2015-06-01 | Iniziato | Needham | Buy |
| 2015-06-01 | Iniziato | Piper Jaffray | Overweight |
Mostra tutto
Collegium Pharmaceutical Inc Borsa (COLL) Ultime notizie
Why Collegium Pharmaceutical Inc. stock is popular among millennialsJuly 2025 Technicals & Verified Entry Point Signals - newser.com
Is Collegium Pharmaceutical Inc. (354) stock in buy zone after pullback2025 Price Targets & AI Optimized Trading Strategy Guides - newser.com
Collegium (COLL) Raises 2025 Revenue Guidance—Is Profitability Momentum Built to Last? - Yahoo Finance
Is Collegium Pharmaceutical Inc. (354) stock a safe buy pre earningsWeekly Trade Recap & Verified Technical Trade Signals - newser.com
A Fresh Look at Collegium Pharmaceutical (COLL) Valuation After Upbeat 2025 Guidance and Strong Q3 Earnings - simplywall.st
How Collegium Pharmaceutical Inc. stock performs during Fed tightening cyclesSwing Trade & Daily Price Action Insights - newser.com
What valuation ratios show for Collegium Pharmaceutical Inc. (354) stockPortfolio Growth Summary & Free Risk Controlled Daily Trade Plans - newser.com
Measuring Collegium Pharmaceutical Inc.’s beta against major indicesPortfolio Profit Report & Growth Oriented Trade Recommendations - newser.com
How Collegium Pharmaceutical Inc. (354) stock reacts to stronger dollarTrade Exit Summary & Expert Curated Trade Ideas - newser.com
Collegium Pharma and Entegris have been highlighted as Zacks Bull and Bear of the Day - sharewise.com
Will Collegium Pharmaceutical Inc. (354) stock justify high valuationEarnings Overview Report & Stepwise Entry/Exit Trade Alerts - newser.com
Will Collegium Pharmaceutical Inc. stock outperform Dow Jones indexQuarterly Earnings Summary & Verified Stock Trade Ideas - newser.com
Bull of the Day: Collegium Pharmaceutical (COLL) - Zacks Investment Research
How to monitor Collegium Pharmaceutical Inc. with trend dashboards2025 Price Momentum & Expert Approved Trade Ideas - newser.com
Why retail investors pile into Collegium Pharmaceutical Inc. stockGlobal Markets & Daily Chart Pattern Signal Reports - newser.com
Is Collegium Pharmaceutical Inc. stock recession proofJuly 2025 Opening Moves & Low Risk Investment Opportunities - newser.com
Can Collegium Pharmaceutical Inc. (354) stock hit consensus price targets2025 Technical Overview & Low Volatility Stock Recommendations - newser.com
Is Collegium Pharmaceutical (COLL) Stock Undervalued Right Now? - sharewise.com
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance Australia
Branded Pharmaceuticals Stocks Q3 Earnings: Eli Lilly (NYSE:LLY) Best of the Bunch - TradingView
Will Collegium Pharmaceutical Inc. (354) stock hit analyst forecastsMarket Rally & Expert-Curated Trade Recommendations - newser.com
Is Collegium Pharmaceutical Inc. (354) stock inflation resilient2025 Top Gainers & Low Risk Entry Point Guides - newser.com
Will Collegium Pharmaceutical Inc. (354) stock profit from automation waveQuarterly Growth Report & Daily Momentum Trading Reports - newser.com
Collegium Pharmaceutical Inc Azioni (COLL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
6.17%
0.67%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):